Machine learning workflows are slow, fragmented, and often require sending sensitive data to cloud services. Revise, a new no-code platform, tries to solve all three problems at once by providing a guided interface for cleaning data, training models, and validating results entirely on your own machine.
The problem with current ML workflows
Even a simple machine learning project can take weeks once you count learning a library, debugging preprocessing code, and waiting for someone else's compute cycle. The inefficiency is not a science problem. It is a tooling problem. The tools that exist are either code-heavy, requiring programming skills that many domain experts do not have, or cloud-based, requiring data to leave the organization's control.
For health AI teams, the cloud problem is not just inconvenient. It is often prohibited. Clinical, biomarker, and survey data frequently fall under IRB or HIPAA restrictions that prevent transmission to external services. Leading AutoML platforms are built cloud-first, which makes them unusable for teams working with regulated data. Revise runs entirely locally, with nothing sent to the cloud.
The skill barrier is equally real. Plenty of researchers and clinicians have a real dataset and a real question but lack the programming background that most ML tools assume. Revise targets this gap directly, providing a guided interface that handles the technical complexity without requiring the user to write scripts.
What Revise actually provides
Tabular and imaging workflows are available now. For tabular data, you upload a spreadsheet, clean it through a guided interface that handles missing values, outliers, and formatting issues, and then train and validate a model. Built-in charts and distributions help you understand your dataset before and after cleaning without needing a plotting library.
For imaging, the platform supports classification, segmentation, and detection on image sets and DICOM files. This is particularly relevant for medical teams working with radiology or pathology data, where DICOM is the standard format and manual annotation is expensive.
Signaling and NLP studios are in development. Signaling will cover biosignals, omics, and time-series modeling. NLP will cover text classification, named entity recognition, and large language model fine-tuning. The development roadmap suggests the platform is building toward a comprehensive toolkit for health AI workflows, not just the two currently available modules.
The parallel model comparison
One of Revise's more practical features is the ability to compare up to eight models in parallel within a single session. Instead of training one model, evaluating it, then training another, you configure multiple model types and let them train simultaneously. The results appear side by side, making it straightforward to pick the best performer.
This matters because model selection is often the most time-consuming part of a small ML project. Training a random forest, a gradient boosting model, a logistic regression, and a neural network on the same data, then comparing their performance, typically requires writing separate training scripts for each one. Revise handles that in a single interface, which reduces the time from hours to minutes and makes it practical to explore more model options than a manual workflow would allow.
What the local-first approach means
Running entirely locally means the platform can handle sensitive data without the compliance overhead of cloud services. But it also means the compute is limited to whatever hardware you have available. For teams with high-end workstations or lab machines with GPUs, this is fine. For teams with standard laptops, training large models on large datasets will be slower than cloud alternatives.
The tradeoff is clear: you get privacy and compliance by keeping data local, but you lose the elastic compute that cloud platforms provide. For many health AI teams, that is the right tradeoff. The data cannot leave the building regardless, so the question is not whether to use cloud compute but whether to use any ML tools at all. Revise makes it possible to use ML tools without violating data governance requirements.
Every trained model is saved automatically. You can host it locally or upload and send it to a collaborator directly through the app. This creates a workflow where the model stays on the same infrastructure as the data, which simplifies deployment for teams that need to keep everything within their own network.
Where it fits in the ML tooling landscape
Revise occupies a specific niche: no-code ML for teams with regulated data who cannot use cloud services. It is not trying to replace PyTorch or scikit-learn for developers who can write their own training loops. It is trying to make ML accessible to people who have the domain knowledge to interpret results but not the programming skills to generate them.
The platform is currently used at two top medical institutions in California, training real models on real clinical datasets. That adoption suggests the local-first, no-code approach is solving a real problem for teams that have been stuck between the data they have and the tools they can use. The question for other teams is whether their workflow fits the tabular and imaging modules available now, or whether they need to wait for the signaling and NLP studios still in development.